Meclizine Hydrochloride Tablets 12.5 mg
American Health Packaging is recalling Meclizine Hydrochloride 12.5 mg tablets (NDC 60687-775-65 and 60687-775-11) due to failed tablet specifications.
Stop using this medication and contact your pharmacy or healthcare provider immediately for a replacement or alternative treatment.
Why it was recalled
American Health Packaging is recalling Meclizine Hydrochloride Tablets, USP 12.5 mg in two package configurations due to failed tablet specifications: 50-tablet blister packs (NDC 60687-775-65) and individual-dose tablets (NDC 60687-775-11). The affected product was distributed nationwide.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Recall #
- D-0418-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Amerisource Health Services LLC
Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification